Long-term survival of ischemic cerebrovascular disease in the acute inflammatory stroke study, a hospital-based cohort described by TOAST and ASCO

Cerebrovascular Diseases

Volumn 35, Issue 3, 2013, Pages 213-219

  Markaki, Ioanna ^a   Franzén, Ida ^a   Talani, Caroline ^a   Loizou, Louiza ^a   Kostulas, Nikolaos ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ASCO; Etiological classification; Ischemic stroke; Survival; Transient ischemic attack; Trial of Org 10172 in Acute Stroke Treatment

Indexed keywords

BILIRUBIN; BIOCHEMICAL MARKER; CHOLESTEROL; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ARTERY OCCLUSION; ARTICLE; ASCO CLASSIFICATION SYSTEM; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CLINICAL OBSERVATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE CLASSIFICATION; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LARGE ARTERY ATHEROSCLEROSIS; LEUKOCYTE COUNT; LONG TERM SURVIVAL; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHENOTYPE; PRIORITY JOURNAL; SMALL ARTERY OCCLUSION; TRANSIENT ISCHEMIC ATTACK; TRIAL OF ORG 10172 IN ACUTE STROKE TREATMENT CLASSIFICATION;

EID: 84874614645     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000346094     Document Type: Article

References (25)

1. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21 637-676
2. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG: Classification of stroke subtypes. Cerebrovasc Dis 2009; 27: 493-501
3. Strong K, Mathers C, Bonita R: Preventing stroke: saving lives around the world. Lancet Neurol 2007; 6: 182-187
4. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke 2001; 32: 2735-2740
5. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41
6. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG: New approach to stroke subtyping: The A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009; 27: 502-508
7. Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, Harris D, Williams EB, Horgan G, Kyne L, McCormack PM, Duggan J, Moore A, Crispino-O'Connell G, Kelly PJ: Stroke subtype classification to mechanism-specific and undetermined categories by Toast, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke 2010; 41: 1579-1586
8. Shang W, Liu J: Stroke subtype classification: A comparative study of ASCO and modified TOAST. J Neurol Sci 2012; 314: 66-70
9. Cotter PE, Belham M, Martin PJ: Towards understanding the cause of stroke in young adults utilising a new stroke classification system (A-S-C-O). Cerebrovasc Dis 2012; 33: 123-127
10. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 2006; 37: 2493-2498
11. McColl BW, Allan SM, Rothwell NJ: Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009; 158: 1049-1061
12. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D'Aguanno G, La Placa S, Pecoraro R, Arnao V, Marino L, Monaco S, Natale E, Licata G, Pinto A: Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009; 215: 84-89
13. Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J: Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry 2011; 82: 986-992
14. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
15. Mogensen UB, Olsen TS, Andersen KK, Gerds TA: Cause-specific mortality after stroke: relation to age, sex, stroke severity, and risk factors in a 10-year follow-up study. J Stroke Cerebrovasc Dis 2012, E-pub ahead of print
16. Li C, Hedblad B, Rosvall M, Buchwald F, Khan FA, Engstrom G: Stroke incidence, recurrence, and case-fatality in relation to socioeconomic position: A population-based study of middle-aged Swedish men and women. Stroke 2008; 39: 2191-2196
17. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke 2000; 31: 1062-1068
18. Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G: Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. Int Angiol 2006; 25: 261-267
19. Olindo S, Cabre P, Deschamps R, Chatot-Henry C, Rene-Corail P, Fournerie P, Saint-Vil M, May F, Smadja D: Acute stroke in the very elderly: epidemiological features, stroke subtypes, management, and outcome in Martinique, French West Indies. Stroke 2003; 34: 1593-1597
20. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C: Association of circulating inflammatory markers with recurrent vascular events after stroke: A prospective cohort study. Stroke 2011; 42: 10-16
21. Herishanu Y, Abramsky O, Lavy S: Hyperbilirubinaemia in acute ischaemic stroke. J Neurol Sci 1971; 14: 417-420
22. Pineda S, Bang OY, Saver JL, Starkman S, Yun SW, Liebeskind DS, Kim D, Ali LK, Shah SH, Ovbiagele B: Association of serum bilirubin with ischemic stroke outcomes. J Stroke Cerebrovasc Dis 2008; 17: 147-152
23. Sevastos N, Savvas SP, Rafailidis PI, Manesis EK: Cholestasis in acute stroke: An investigation on its prevalence and etiology. Scand J Gastroenterol 2005; 40: 862-866
24. Lin JP, Vitek L, Schwertner HA: Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010; 56: 1535-1543
25. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA: Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008; 121: 781-788, e781.